Substance Abuse Information and Resources for Healthcare Providers


Prescribing and Screening Tools


Minnesota’s opioid prescribing guidelines

Published March 2018

CDC Guideline for Prescribing Opioids for Chronic Pain

Published March 2016

Calculating total daily dosage of opioids for safer dosage

The MN PMP utilizes the CDC’s published conversion factors.  Per the CDC, “The MME conversion factor is intended only for analytic purposes where prescription data are used to retrospectively calculate daily MME to inform analyses of risks associated with opioid prescribing. This value does not constitute clinical guidance or recommendations for converting patients from one form of opioid analgesic to another. Please consult the manufacturer’s full prescribing information for such guidance. Use of this file for the purposes of any clinical decision-making warrants caution. This is particularly true with regard to methadone. Calculating MME for methadone in clinical practice often involves a sliding-scale approach whereby the conversion factor increases with increasing dose. The conversion factor of 3 for methadone presented in this file could underestimate MME for a given patient. Please see clinical guidance provided here: .”

National Institute on Drug Abuse for Medical & Health Professionals ( NIDAMED)

This website provides many science-based, up-to-the-minute resources for physicians, medical school faculty and students. They include drug use screening tools, opioid prescribing resources, drug abuse information, addiction information, treatment information and materials for patient education.

Opioid Overdose Prevention Toolkit

This toolkit was created by the Substance Abuse and Mental Health Services Administration (SAMHSA). This toolkit addresses issues for first responders, treatment providers, and those recovering from opioid overdose.  Updated 2016

Joint Statement on Pain Management

 A joint statement on pain management was developed by the Minnesota Boards of Medical Practice, Nursing, and Pharmacy in 2009. The statement was updated and approved in December of 2015. This statement provides recommendations for effective pain management.

Joint Statement on Prescribing Opioid Antagonist (Naloxone)

A joint statement on prescribing opioid antagonists was developed by the Minnesota Boards of Medical Practice, Nursing and Pharmacy in 2018.  This statement provides recommendations for healthcare providers in the use of opioid antagonists, such as naloxone.

MN Board of Dentistry Statement on Safe Prescribing and the Use of Opioids in Dental Settings

The Minnesota Board of Dentistry considered relevant literature, model policies, as well as local and national resources and issued a statement to offer guidance to dental providers in the management of pain.

Institute for Clinical Systems Improvement (ICSI): Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management guideline

This guideline is a combination of ICSI’s Acute Pain Assessment/Opioid Prescribing Protocol and the Assessment and Management of Chronic Pain guidelines. Our new guideline now addresses the entire continuum for acute, sub-acute, and chronic non-cancer pain in adults. Updated September 2016

Acute Pain Management in the Emergency Department

American Academy of Emergency Medicine White Paper.  Approved October 2017

Sample Patient Agreement Forms

This resource produced by the National Institute on Drug abuse includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other controlled substances.


Treatment Resources is a website intended to provide resources and awareness regarding the opioid crisis in Minnesota. This site is presented by the Minnesota Dept of Human Services (MN DHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA). includes a naloxone locator tool. NALOXONE FINDER Enter an address or zip code to find lifesaving naloxone near you. 

Fast Tracker MNFast Tracker is a virtual community and healthcare connection resource. The Fast Tracker connects individuals, families, mental health and substance use disorders providers, physicians, care coordinators, and others with a real-time, searchable directory of substance use disorder resources and their availability within Minnesota. Participation by healthcare providers is optional and providers are expected to update availability on a daily basis. 

Screening, Brief Intervention, and Referral to Treatment (SBIRT)

SBIRT is a public health approach to the delivery of early intervention and treatment services for people with substance use disorders and those at risk of developing these disorders. Substance Abuse and Mental Health Services Administration (SAMHSA) has resources and information on the SBIRT program. 

Behavioral Health Treatment Services Locator

The Substance Abuse and Mental Health Services Administration (SAMHSA) has a tool called the Behavioral Health Treatment Services Locator. It is an on-line source of information for persons seeking treatment facilities in the United States or U.S. Territories for substance abuse/addiction and/or mental health problems.

MinnesotaHelp is a statewide online resource for drug abuse information.  The site provides chemical health education and resources for providers, families, and individuals.  Information includes drug abuse treatment programs, crisis intervention, counseling, support groups, and help for families.

SAMHSA Advisory: Buprenorphine for Opioid Use Disorder

An Advisory intended for prescribing physicians and other healthcare professionals on the use of buprenorphine for the medication assisted treatment of opioid use disorder. Published March 2016



© 2023 Bamboo Health, All rights reserved.

MN Prescription Monitoring Program | 335 Randolph Avenue, Suite 230 |  Saint Paul, Minnesota 55102 Voice: 651-201-2836 | Fax: 651-215-0948